Health Plan Notification and Feedback to Providers is Associated with Increased Filling of Preventer Medications for Children with Asthma Enrolled in Medicaid - 07/03/14
⁎ 
, Wayne A. Ray, PhD †, Patrick G. Arbogast, PhD ‡, Michelle Garrison, PhD §, Judith A. Dudley †, Dimitri A. Christakis, MD, MPH § Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN Reprint requests: William O. Cooper, MD, MPH, Department of Pediatrics, Vanderbilt University Medical Center, AA-0216 MCN, Nashville, TN 37232-2504.Résumé |
Objective |
To test the hypothesis that children enrolled in Medicaid managed care health plans that provide asthma-specific communication to providers would be more likely to have adequate asthma medication filling.
Study Design |
We conducted a historical cohort study of 4498 children (2-17 years old) with moderate-severe asthma in Washington State and Tennessee Medicaid managed care programs from 2000 to 2002. Interviews with health plans were conducted to identify communication strategies health plans used to improve asthma care by providers in the plan. The main outcome measure was guideline-recommended filling of asthma preventer medications.
Results |
Children in plans that provided specific feedback to providers about asthma quality and notified providers when children had an asthma-related event had the highest mean days plus or minus SE of filling in the 365-day follow-up period (164.6 ± 13 days) compared with children in plans with neither (135.3 ± 10.8 days; P < .05). In children with the greatest asthma severity, enrollment in a plan with both features was associated with 27.1 additional days of filling (95% CI, 0.7-53.4 days) during the follow-up period.
Conclusion |
Health plan communication to providers was associated with increased preventer filling in children with moderate-severe asthma in 2 state Medicaid programs.
Le texte complet de cet article est disponible en PDF.Abbreviations : HCFA, ICD-9-CM, MMC
Plan
| Conflicts of Interest: Drs Ray and Arbogast report receiving grant support from Pfizer for work unrelated to the research reported in this manuscript. |
|
| Supported by the Agency for Healthcare Research and Quality (HS#13076) and the Agency for Healthcare Research and Quality, Centers for Education and Research on Therapeutics (HS#10384). The funders had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; and preparation, review, or approval of the manuscript. The first draft was written by Dr Cooper. |
Vol 152 - N° 4
P. 481-488 - avril 2008 Retour au numéro
Article précédent
- The Pediatric Respiratory Assessment Measure: A Valid Clinical Score for Assessing Acute Asthma Severity from Toddlers to Teenagers
- Francine M. Ducharme, Dominic Chalut, Laurie Plotnick, Cheryl Savdie, Denise Kudirka, Xun Zhang, Linyan Meng, David McGillivray
- 50 Years Ago in The Journal of Pediatrics : Pseudotumor cerebri: Benign intracranial hypertension
- Paul Graham Fisher
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?